Streetbeat News

Products Services

AXTI

AXT, Inc. (NASDAQ:AXTI) shares surged premarket after reporting Q4 financial results that exceeded expectations. Revenue reached $20.4 million, surpassing the consensus of $17.6 million and showing improvement from previous quarters. Adjusted operating expenses decreased, and the company noted a widening operating loss. Despite a year-over-year decline in adjusted EPS, AXTI highlighted a recovery in its markets, particularly in demand for indium phosphide for AI and fiber optic applications, expecting AI to drive future demand.

Portfolio Pulse from Lekha Gupta

February 23, 2024 | 12:51 pm

MAGS

NVDA

Nvidia Corporation's (NASDAQ:NVDA) latest earnings report has significantly increased chip demand for AI projects, boosting its stock and the Roundhill Magnificent Seven ETF (NASDAQ:MAGS), which includes Nvidia among its holdings. The MAGS ETF saw a 4% rise and record trading volume following Nvidia's earnings, with analysts optimistic about further growth in tech stocks, especially those related to AI. Despite concerns about market concentration and Nvidia's dependency on other Magnificent 7 companies, the outlook for Nvidia and the MAGS ETF remains positive.

Portfolio Pulse from Benzinga Neuro

February 23, 2024 | 12:49 pm

ATNM

Actinium Pharmaceuticals, Inc. announced positive results from the SIERRA trial for Iomab-B in TP53 positive relapsed refractory acute myeloid leukemia patients, presented at the 2024 Transplantation & Cellular Therapy Meetings of ASTCT And CIBMTR. The results highlight improved survival rates, marking a significant advancement in treatment options for this patient group.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 12:43 pm

LEGN

Legend Biotech announced that the Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion on CARVYKTI (ciltacabtagene autoleucel) for treating patients with relapsed and lenalidomide refractory multiple myeloma in earlier lines of therapy. This marks a significant milestone for Legend Biotech, potentially enhancing its market position and product portfolio.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 12:16 pm

AAPL

Apple Inc.'s (NASDAQ:AAPL) Vision Pro users report unexplained cracks in the device's front glass, leading to potential $800 repair bills. The issue, highlighted by multiple Reddit users, occurs at the nose bridge, suggesting a design flaw. Apple advises affected users to pay a deductible for repairs, raising concerns about the device's durability and cost-effectiveness. This adds to previous concerns about the device's scratch resistance and user comfort.

Portfolio Pulse from Rounak Jain

February 23, 2024 | 12:11 pm

CMND

Clearmind Medicine has announced receiving approval to start a Phase I/IIa clinical trial for its drug CMND-100, aimed at treating Alcohol Use Disorder.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 12:08 pm

CSLLY

TVTX

Travere Therapeutics and CSL Vifor announced that the European Medicines Agency's CHMP has recommended approval of Sparsentan for primary IgA Nephropathy with a urine protein excretion >1.0 g/day. A decision from the European Commission is expected in Q2 2024.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 12:07 pm

UNFI

United Natural Foods (UNFI) announced it showcased solutions to help grocery retail customers thrive in a competitive market, emphasizing its commitment to supporting its clients' success.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 12:07 pm

BCRX

BioCryst Pharmaceuticals announced that new analyses of real-world use of Orladeyo (Berotralstat), an oral, once-daily treatment, demonstrated that patients experienced rapid, substantial, and sustained reductions in attack rates through 18 months of treatment.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 12:05 pm

PLUG

Plug Power and Uline have expanded their partnership to deploy hydrogen infrastructure and fuel cell solutions at Uline's new campus in Kenosha, Wisconsin. This collaboration aims to enhance operational efficiency and sustainability at the facility.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 12:03 pm